Blood glucose and the brain in diabetes: Between a rock and a hard place? Mark L. EvansRobert S. Sherwin Invited Commentary Pages: 101 - 102
The use of insulin in critically III patients William E. Winter Clinical Trials Report Pages: 109 - 110
Diagnosis, screening, and management of cystic fibrosis–related diabetes Antoinette Moran OriginalPaper Pages: 111 - 115
HIV-associated lipodystrophy: Description, pathogenesis, and molecular pathways Patrick W. G. MallonAndrew CarrDavid A. Cooper OriginalPaper Pages: 116 - 124
Molecular etiologies of mody and other early-onset forms of diabetes David Q. ShihMarkus Stoffel OriginalPaper Pages: 125 - 134
Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents David C. Henderson OriginalPaper Pages: 135 - 140
Computer-based automated aids to assist patient care and self-management Russell E. Glasgow Clinical Trials Report Pages: 143 - 144
Patient-centered diabetes self-management education Geoffrey C. WilliamsAllan Zeldman OriginalPaper Pages: 145 - 152
Emotional and quality-of-life aspects of diabetes management William H. Polonsky OriginalPaper Pages: 153 - 159
Reaching underserved populations and cultural competence in diabetes education Sharon A. BrownAlexandra A. GarciaMaria Winchell OriginalPaper Pages: 166 - 176
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity Francesco S. CeliAlan R. Shuldiner OriginalPaper Pages: 179 - 185
